AI-Powered 3D heart scan could revolutionize valve leak diagnosis

NCT ID NCT07528781

Recruiting now Diagnosis Sponsor: Germans Trias i Pujol Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new artificial intelligence software that uses 3D echocardiography to measure mitral regurgitation (a leaky heart valve) more accurately than the standard 2D method. Researchers will compare the 3D tool against cardiac MRI, the current gold standard, in 200 adults with moderate or severe mitral regurgitation. If successful, the tool could help doctors make faster and better treatment decisions, especially during emergency procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE OR SEVERE MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

follicular lymphoma mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MODERATE OR SEVERE MITRAL REGURGITATION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital University Germans Trias i Pujol
RECRUITING

Badalona, Barcelona, 08916, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••